In our present study, we found that in addition to effector Tregs, CD39+ ATLL cells themselves have immunosuppressive function, which appears to allow leukemic cells to overcome and escape from host antitumor immunity, thus promoting the disease. This evidence concerns the gene ENTPD1 and adult T-cell leukemia/lymphoma.